Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy

Abstract Background: Randomized trials evaluating intensive dose statin therapy have found enhanced protection against cardiovascular (CV) events compared with moderate-dose statin therapy in patients with acute coronary syndromes (ACS) or stable coronary artery disease (CAD). However, the potential...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical therapeutics 2007-02, Vol.29 (2), p.253-260
Hauptverfasser:	Silva, Matthew, PharmD, RPH, BCPS, Matthews, Michele L., PharmD, RPh, Jarvis, Courtney, PharmD, Nolan, Nicole M., PharmD, RPh, Belliveau, Paul, PharD, RPh, Malloy, Michael, PharmD, Gandhi, Pritesh, PharmD, BCPS
Format:	Artikel
Sprache:	eng
Schlagworte:	Anticholesteremic Agents - administration & dosage Anticholesteremic Agents - adverse effects Anticholesteremic Agents - therapeutic use atorvastatin Biological and medical sciences Cardiovascular Diseases - prevention & control Dose-Response Relationship, Drug Female Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Hypercholesterolemia - drug therapy intensive-dose Internal Medicine Male Medical Education Medical sciences Middle Aged Pharmacology. Drug treatments Randomized Controlled Trials as Topic Risk Factors simvastatin statins adverse events
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!